Each delivered dose contains:
Indacaterol 85 micrograms
Glycopyrronium 43 micrograms
Other ingredients include lactose monohydrate (contains milk proteins) and magnesium stearate.
Ultibro Breezhaler
Manufacturer: Novartis Pharmaceuticals UK Limited
Prescription required
Ultibro Breezhaler is a prescription-only maintenance inhalation treatment for adults with chronic obstructive pulmonary disease (COPD).
It contains two long-acting bronchodilators, indacaterol and glycopyrronium, which help keep the airways open and relieve ongoing breathing symptoms.
Ultibro Breezhaler is taken once daily using the supplied inhaler device.
It is not suitable for treating asthma or providing immediate relief during sudden breathing difficulties.
Treatment requires an appropriate clinical assessment and a valid prescription.
Each delivered dose contains:
Indacaterol 85 micrograms
Glycopyrronium 43 micrograms
Other ingredients include lactose monohydrate (contains milk proteins) and magnesium stearate.